{"filing":{"accession_number":"0001437749-26-024522","cik":"0000832489","ticker":"GOVX","company_name":"GeoVax Labs, Inc.","form":"8-K","filing_date":"2026-07-27","report_date":"2026-07-27","primary_document":"govx20260727_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926024522/govx20260727_8k.htm"},"events":[{"id":20740,"run_id":18666,"accession_number":"0001437749-26-024522","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"GeoVax issued a press release on July 27, 2026, reporting financial results for the quarter ended June 30, 2026, disclosing net loss of $4.4 million (Q2 2026) versus $5.4 million (Q2 2025), revenue decline to $0 (loss of BARDA contract), and R\u0026D expense reductions. The filing explicitly states \"the Company issued a press release reporting its results of operations for the quarter ended June 30, 2026\" with the press release attached as Exhibit 99.1, which is the standard format for an earnings release under Item 2.02.","company_name":"GeoVax Labs, Inc.","ticker":"GOVX","filing_date":"2026-07-27","form":"8-K","submitted_at":null,"items":[{"id":20197,"accession_number":"0001437749-26-024522","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"GeoVax issued a press release on July 27, 2026, reporting financial results for the quarter ended June 30, 2026, disclosing net loss of $4.4 million (Q2 2026) versus $5.4 million (Q2 2025), revenue decline to $0 (loss of BARDA contract), and R\u0026D expense reductions. The filing explicitly states \"the Company issued a press release reporting its results of operations for the quarter ended June 30, 2026\" with the press release attached as Exhibit 99.1, which is the standard format for an earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-27T20:35:38.058316+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20197,"accession_number":"0001437749-26-024522","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"GeoVax issued a press release on July 27, 2026, reporting financial results for the quarter ended June 30, 2026, disclosing net loss of $4.4 million (Q2 2026) versus $5.4 million (Q2 2025), revenue decline to $0 (loss of BARDA contract), and R\u0026D expense reductions. The filing explicitly states \"the Company issued a press release reporting its results of operations for the quarter ended June 30, 2026\" with the press release attached as Exhibit 99.1, which is the standard format for an earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-27T20:35:38.058316+00:00","company_name":"GeoVax Labs, Inc.","ticker":"GOVX","filing_date":"2026-07-27"}]}